2018 US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends

- How will the future reimbursement changes affect individual market segments?

- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?

- How will the future technological advances affect the major market segments?

- Which companies will enter the market and which will not survive?

These and other key strategic issues facing decision-makers are explored in this thought-provoking and multi-faceted portrait of the future U.S. in vitro diagnostics market.

This invaluable strategic planning resource is designed to help corporate, marketing and R&D executives develop effective business plans that best accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop realistic contingency plans.

The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact; as well as five- and ten-year test volume and sales forecasts for major testing locations (hospitals, commercial labs, physician offices, blood centers, POC sites, and others) and laboratory disciplines (blood banking, clinical chemistry, immunodiagnostics, coagulation, hematology, flow cytometry, histology, cytology, microbiology, serology, urinalysis and others).

I. Executive Summary
2. Conclusions and Recommendations
3. Business Environment
a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
- More Chronic Illnesses
- Higher Incidence of Disease
- Greater Susceptibility to Iatrogenesis
- More Cases with Multiple Illnesses
4. Outlook for the In Vitro Diagnostics Market
a. Government Regulations
b. FDA Reform
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations
5. Strategic Implications
a. Testing Patterns
- Test Utilization
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
6. Market Segments
a. Clinical Chemistry and Immunodiagnostics
- Introduction
- Future Situation
b. Microbiology and Serology
- Introduction
- Future Situation
c. Hematology and Flow Cytometry
- Introduction
- Future Situation
d. Blood Banking
- Introduction
- Future Situation
e. Histology and Cytology
- Introduction
- Future Situation
f. Coagulation
- Introduction
- Future Situation
g. Urinalysis
- Introduction
- Future Situation
7. Technologies
a. Molecular Diagnostics
- Introduction
- Future Situation
b. Monoclonal Antibodies
- Introduction
- Future Situation
c. Solid Phase Chemistry
- Introduction
- Future Situation
d. Biosensors and Biochips
- Introduction
- Future Situation
e. Automation and Robotics
- Introduction
- Future Situation
f. IT
- Introduction
- Future Situation
8. The New Marketplace
a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?

List Of Tables

Executive Summary Table: Growth Areas in Clinical Laboratory Testing
Table-1: Estimated U.S. Health Care Expenditures By Type
Table-2: Health Plan Enrollment Distribution
Table-3: Selected Hospital Statistics
Table-4: Total Population And Physician Demographics
Table-5: Test Volume By Location
Table-6: Test Distribution By Location
Table-7: Market Size By Location
Table-8: Typical Pre-Admission Tests
Table-9: Test Volume By Laboratory Discipline
Table-10: Market Size By Laboratory Discipline

Global Interventional Cardiology Devices Market (2018-2023)

Global Interventional Cardiology Devices Market (2018-2023) market research report available in single user pdf license with Aarkstore Enterprise at USD 2950

USD 2950 View Report

Global Corporate Wellness Market (2018-2023)

The global corporate wellness market is forecast to expand at a CAGR of 4.95%, and will reach a value of USD 61.95 Bn by 2023. The Report also Provides highest revenue and market share.

USD 2950 View Report

Zika Virus Infections - Pipeline Review, H2 2019

Zika Virus Infections - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections - Pipeline Review, H2 2019, provides an overview of the Zika Virus Infections

USD 2000 View Report

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2019

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Haemophilus influenzae Type B Infections - Pipeline Review, H2 2019, provides an overview of

USD 2000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available